Pharmafile Logo
Pharmafocus logo
Advanced Search
tablets

Ibuprofen linked to 31% increase in risk of cardiac arrest

March 16, 2017
Medical Communications cardiac arrest, ibuprofen

A study emerging from Denmark has found that the use of over-the-counter pain killer, Ibuprofen, is associated with an increased …

News

SHL to Present at Pharmapack Symposium Taiwan 2017

March 16, 2017
Manufacturing and Production auto injectors, extractables and leachables, prefilled syringe

Olle Ljungquist, Senior Scientist at SHL Group, will give a talk on the “Requirements and Test Methods for Finished Prefilled …

News
Press release
heartbeat

Decade lifespan difference in Americans and Canadians with cystic fibrosis

March 15, 2017
Research and Development Canada, United States, cystic fibrosis

A new study has emerged looking into life expectancy of those with cystic fibrosis, funded by the US Cystic Fibrosis …

News
opdivo_1_1

NICE recommends against Opdivo for classical Hodgkin lymphoma

March 15, 2017
Research and Development, Sales and Marketing BMS, classical Hodgkin Lymphoma, opdivo

The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab) …

News
shutterstock_156022646

FDA-approved preterm birth drug has no benefit and may cause harm, study suggests

March 15, 2017
Research and Development FDA, Makena

A study by the UT Southwestern Medical Center has found that the synthetic progestogen hormone 17-alpha hydroxyprogesterone caproate (17-OHPC), a …

News
merck_and_co

MSD’s Keytruda notches another FDA approval in Hodgkin lymphoma

March 15, 2017
Research and Development, Sales and Marketing Hodgkin lymphoma, MSD, keytruda

MSD, otherwise known as Merck in North America, continues to score indication successes with Keytruda, this time in Hodgkin lymphoma. …

News
sanofi_new_paris_hq

Patients in UK to be given early access to Sanofi’s eczema treatment

March 14, 2017
Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi

Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …

News

Novartis secures first-line FDA approval in breast cancer indication

March 14, 2017
Manufacturing and Production, Sales and Marketing Kisqali, Novartis, breast cancer

The FDA has approved Kisqali (ribociclib) in combination with letrozole for the first-line treatment of postmenopausal women with hormone receptor …

News
cancer_cells

Survivors of Hodgkin lymphoma over twice as likely to suffer second cancer

March 14, 2017
Manufacturing and Production, Research and Development Hodgkin lymphoma, ICR

New research emerging from the Institute for Cancer Research (ICR) has found that those previously treated for Hodgkin lymphoma are …

News
sun_pharma

FDA lifts block on Sun Pharma facility

March 14, 2017
Manufacturing and Production FDA, Sun Pharma

Sun Pharma has announced that the FDA informed it that the Import Alert in place upon its Mohali manufacturing facility …

News
breast_cancer

One in five women with breast cancer could benefit from existing therapy

March 14, 2017
Manufacturing and Production, Research and Development Wellcome Trust Sanger Institute, breast cancer, parp inhibitors

A new study emerging from the Wellcome Trust Sanger Institute has discovered that there are more cases of breast cancer …

News
deborah

XTuit Pharmaceuticals move to appoint biotech veteran as CEO

March 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing XTuit Pharmaceuticals

XTuit Pharmaceuticals has revealed the appointment of Deborah Dunshire as its new President and CEO. XTuit Pharmaceuticals is a biotech …

Appointment
mylan

Mylan’s pathway to launch of biosimilar to Herceptin cleared by Roche

March 13, 2017
Manufacturing and Production, Sales and Marketing Genentech, Herceptin, Mylan, Roche, biosimilar

Mylan scored a big victory in its plan to launch its biosimilar to Roche’s blockbuster, Herceptin, after Roche and itself …

News
shutterstock_141299494

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …

Feature
shutterstock_212432119

Combination immunotherapy shows promise in castration-resistant prostate cancer

March 13, 2017
Research and Development, Sales and Marketing prostate cancer

Researchers at the University of Texas MD Anderson Cancer Center have found that castration-resistant prostate cancer responds well to a …

News
karyopharm_therapeutics

Bad start to month for Karyopharm gets worse with clinical hold

March 13, 2017
Sales and Marketing Karyopharm

Coming just over a week after Karyopharm Therapeutics had announced that its lead drug had failed in a Phase 2 …

News
pfizer_brussels

Pfizer announces partnership with UK university

March 13, 2017
Medical Communications, Sales and Marketing Pfizer, Swansea University

Pfizer and Swansea University have announced plans to collaborate on a new Innovation Hub at Swansea University’s new £450 million …

News

Trump makes choice on new FDA head

March 13, 2017
Medical Communications, Sales and Marketing FDA, Gottlieb, Trump

Dr. Scott Gottlieb is Trump’s chosen nominee for the role of commissioner of the FDA. The nomination appeases fears within …

News
320px-human_embryonic_stem_cells_only_a

TiGenix announces success of novel heart attack stem cell trial

March 13, 2017
Research and Development, Sales and Marketing Stem cells, TiGenix, heart attack

Belgium’s TiGenix has announced the success of its top-line Phase 2/3 study investigating the effects of donor-derived expanded cardiac stem …

News
oxford-biodynamics-logo

Oxford BioDynamics installs new SVP of Commercial Development

March 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioDynamics

Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …

Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026